Literature DB >> 19287105

The proteome of mesenteric lymph during acute pancreatitis and implications for treatment.

Anubhav Mittal1, Anthony R J Phillips, Martin Middleditch, Katya Ruggiero, Benjamin Loveday, Brett Delahunt, Garth J S Cooper, John A Windsor.   

Abstract

CONTEXT: The protein fraction of mesenteric lymph during acute pancreatitis and other critical illness is thought to contain toxic factors. However, we do not have a complete description of the mesenteric lymph proteome during acute pancreatitis.
OBJECTIVE: The aim of this study was to define the proteomic changes in mesenteric lymph during acute pancreatitis.
SETTING: Animal Laboratory, University of Auckland, New Zealand.
DESIGN: Mesenteric lymph was collected from sixteen male Wistar rats randomised to Group 1 (n=8) with taurocholate induced acute pancreatitis and Group 2 (n=8) sham control. The lymph was subjected to proteomic analysis using iTRAQ (Applied Biosystems, Foster City, CA, USA) and liquid chromatography-tandem mass spectrometry.
RESULTS: Two hundred and forty-five proteins including 35 hypothetical proteins were identified in mesenteric lymph. Eight of the 245 proteins had a significant increase in their relative abundance in acute pancreatitis conditioned mesenteric lymph, and 7 of these were pancreatic catabolic enzymes (pancreatic amylase 2, pancreatic lipase, carboxypeptidase A2, chymotrypsinogen B, carboxypeptidase B1, cationic trypsinogen, ribonuclease 1).
CONCLUSIONS: This is the first comprehensive description of the proteome of mesenteric lymph during acute pancreatitis and has demonstrated a significantly increased relative abundance of 7 secreted pancreatic catabolic enzymes in acute pancreatitis conditioned mesenteric lymph. This study provides a clear rationale for further research to investigate the efficacy of enteral protease inhibitors in the treatment of acute pancreatitis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19287105

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


  16 in total

1.  Proteomic analysis of human mesenteric lymph.

Authors:  Monika Dzieciatkowska; Max V Wohlauer; Ernest E Moore; Sagar Damle; Erik Peltz; Jeffrey Campsen; Marguerite Kelher; Christopher Silliman; Anirban Banerjee; Kirk C Hansen
Journal:  Shock       Date:  2011-04       Impact factor: 3.454

2.  The Dendritic Cell Major Histocompatibility Complex II (MHC II) Peptidome Derives from a Variety of Processing Pathways and Includes Peptides with a Broad Spectrum of HLA-DM Sensitivity.

Authors:  Cristina C Clement; Aniuska Becerra; Liusong Yin; Valerio Zolla; Liling Huang; Simone Merlin; Antonia Follenzi; Scott A Shaffer; Lawrence J Stern; Laura Santambrogio
Journal:  J Biol Chem       Date:  2016-01-06       Impact factor: 5.157

3.  Carrying yourself: self antigen composition of the lymphatic fluid.

Authors:  Laura Santambrogio; Lawrence J Stern
Journal:  Lymphat Res Biol       Date:  2013-09-11       Impact factor: 2.589

4.  The lymph as a pool of self-antigens.

Authors:  Cristina C Clement; Olaf Rotzschke; Laura Santambrogio
Journal:  Trends Immunol       Date:  2010-12-01       Impact factor: 16.687

Review 5.  Lymphatic dysfunction in critical illness.

Authors:  Edmund Burke; Sanjeev A Datar
Journal:  Curr Opin Pediatr       Date:  2018-06       Impact factor: 2.856

Review 6.  Proteomics as a systems approach to pancreatitis.

Authors:  John A Williams
Journal:  Pancreas       Date:  2013-08       Impact factor: 3.327

Review 7.  Lymphatic Vessel Network Structure and Physiology.

Authors:  Jerome W Breslin; Ying Yang; Joshua P Scallan; Richard S Sweat; Shaquria P Adderley; Walter L Murfee
Journal:  Compr Physiol       Date:  2018-12-13       Impact factor: 9.090

8.  Lymph is not a plasma ultrafiltrate: a proteomic analysis of injured patients.

Authors:  Monika Dzieciatkowska; Angelo D'Alessandro; Ernest E Moore; Max Wohlauer; Anirban Banerjee; Christopher C Silliman; Kirk C Hansen
Journal:  Shock       Date:  2014-12       Impact factor: 3.454

9.  Dynamic changes in rat mesenteric lymph proteins following trauma using label-free mass spectrometry.

Authors:  Angelo D'Alessandro; Monika Dzieciatkowska; Erik D Peltz; Ernest E Moore; Janeen R Jordan; Christopher C Silliman; Anirban Banerjee; Kirk C Hansen
Journal:  Shock       Date:  2014-12       Impact factor: 3.454

Review 10.  Contribution of the plasma and lymph Degradome and Peptidome to the MHC Ligandome.

Authors:  Laura Santambrogio; Hans-Georg Rammensee
Journal:  Immunogenetics       Date:  2018-10-20       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.